![側(cè)腦室注射腎上腺髓質(zhì)素對(duì)大鼠心血管相關(guān)核團(tuán)c-fos表達(dá)及一氧化氮神經(jīng)元的影響_第1頁(yè)](http://file4.renrendoc.com/view10/M02/2F/23/wKhkGWV_MxqAIFtIAAK1Aog9XFQ437.jpg)
![側(cè)腦室注射腎上腺髓質(zhì)素對(duì)大鼠心血管相關(guān)核團(tuán)c-fos表達(dá)及一氧化氮神經(jīng)元的影響_第2頁(yè)](http://file4.renrendoc.com/view10/M02/2F/23/wKhkGWV_MxqAIFtIAAK1Aog9XFQ4372.jpg)
![側(cè)腦室注射腎上腺髓質(zhì)素對(duì)大鼠心血管相關(guān)核團(tuán)c-fos表達(dá)及一氧化氮神經(jīng)元的影響_第3頁(yè)](http://file4.renrendoc.com/view10/M02/2F/23/wKhkGWV_MxqAIFtIAAK1Aog9XFQ4373.jpg)
![側(cè)腦室注射腎上腺髓質(zhì)素對(duì)大鼠心血管相關(guān)核團(tuán)c-fos表達(dá)及一氧化氮神經(jīng)元的影響_第4頁(yè)](http://file4.renrendoc.com/view10/M02/2F/23/wKhkGWV_MxqAIFtIAAK1Aog9XFQ4374.jpg)
![側(cè)腦室注射腎上腺髓質(zhì)素對(duì)大鼠心血管相關(guān)核團(tuán)c-fos表達(dá)及一氧化氮神經(jīng)元的影響_第5頁(yè)](http://file4.renrendoc.com/view10/M02/2F/23/wKhkGWV_MxqAIFtIAAK1Aog9XFQ4375.jpg)
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
側(cè)腦室注射腎上腺髓質(zhì)素對(duì)大鼠心血管相關(guān)核團(tuán)c-fos表達(dá)及一氧化氮神經(jīng)元的影響
ad-lom是一個(gè)或一個(gè)新的h-fad生命。它可以分為52個(gè)二級(jí)生命。就像人類(lèi)的直接科學(xué)一樣。這是第50個(gè)二級(jí)生命。它與22個(gè)二級(jí)生命測(cè)試系統(tǒng)(c)相對(duì)應(yīng)。另一方面,從屬于授權(quán)管理的家庭報(bào)告(c),即參與政治報(bào)告的家庭報(bào)告(cd)。這是中央非公共行政機(jī)構(gòu)的活動(dòng),無(wú)論是參與政治事務(wù)的人還是參與政治事務(wù)的人,無(wú)論是參與政治事務(wù)的人還是非預(yù)算活動(dòng)。此外,正如第二行感染可卡因子的卡結(jié)算運(yùn)動(dòng),無(wú)論是短程微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng),無(wú)論是非預(yù)算微電話的卡結(jié)算運(yùn)動(dòng)。1杏仁杏仁1.1table3:抗混合物的樹(shù),5.4年4.3日MaleSprague-Dawleyrats(weighing250~300g)wereobtainedfromtheExperimentalAnimalCenterofHebeiProvince.Ratswerehousedina12:12hlight/darkcycleat23~25℃andgivenfreeaccesstofoodandwater.1.2u3000態(tài)Ratswereanaesthetizedwithsodiumpentobarbital(40mg/kg;i.p.)andthenplacedinastereotaxicframeinaproneposition.Astainlesssteelguidecannula(550μmo.d.;10mmlength)withaninternalcannulawasimplantedintotherightlateralcerebralventriclestereotaxically,followingthecoordinatesgivenintheatlasofPaxinonsandWatson.Thesecoordinateswere0.8mmposteriortobregma,1.5mmlateraltomidline,and3.5-4.0mmbelowthesurfaceofskull.Theguidecannulawasfixedwithtwoscrewsontheskullanddentalcement,andtheinternalcannulawasreplacedwithadummycannulatoclosetheguidecannula.Aperiodof7dwasallowedfortherecoveryoftheanimals.Theanimalswerehandledeverydaybeforebeginningtheexperimentssothattheybecameaccustomedtoexperimentalprocedures.1.3utioninpced方法ADM(1nmol/kgand3nmol/kg,Sigma)andCGRP8-37(30nmol/kg,Sigma)weredissolvedinsterilesaline,thetotalvolumeofsolutioninjectedintothelateralventriclewas10μl;controlratsreceivedi.c.v.injectionof10μlsaline.Fori.c.v.administrationofthesolution,astainlesssteelinjector(300μmo.d.)wasintroducedthroughthecannaulatoadepthof1mmbeyondtheendoftheguide.Theanimalswereused120minafteri.c.v.injectionofADM,CGRP8-37orsalineforimmunohistochemistry.1.4ratswrein數(shù)據(jù)和第.3.3.4和khack............................................................3.3.3.Inthefirstexperiment,i.c.v.administrationofADM(1nmol/kg,3nmol/kg)orvehiclewasperformed.Inthesecondexperiment,theeffectsofCGRP8-37(30nmol/kg)ontheactionsofADM(3nmol/kg)wereexamined.Inthisexperiment,ratsweredividedintofourgroups(n=6ineachgroup).Group1vehicle+vehicle:5μlsalinewasi.c.v.injected,and20minlater,administrationofanother5μlsalinewascarriedout.Group2vehicle+ADM:5μlsalinewasi.c.v.injected,and20minlater,administrationofADM(3nmol/kg,5μl)wascarriedout.Group3CGRP8-37+ADM:CGRP8-37(30nmol/kg,5μl)wasi.c.v.injected,and20minlater,administrationofADM(3nmol/kg,5μl)wascarriedout.Group4CGRP8-37+vehicle:CGRP8-37(30nmol/kg,5μl)wasi.c.v.injected,and20minlater,administrationof5μlsalinewascarriedout.1.5which-通過(guò)perfoperation-rexetin-paracting,which-通過(guò)cohenalge-roxetin-parain,which-atinblot,which-pcras,which-pcras,which-pcra著,ats-paras,ntranalsexetraced,which-pcra著,ats-pcras,ntransictory,ets,pbs的表達(dá)Theanimalsweredeeplyanesthetizedbyi.p.injectionofsodiumpentobarbital(80mg/kg),andthentranscardiallyperfusedwith150mlofsaline.Theratswerethenperfusedwithapproximately500mloffixative,whichcontained4%paraformaldehydeand0.2%picricacidin0.1mol/Lphosphatebuffer(pH7.2~7.4).Thebrainwasremovedandpostfixedinthesamefixativeatroomtemperaturefor4~6h,andthentransferredtoa25%sucrosesolutioncontaining0.1mol/Lphosphatebufferovernightat4℃.Coronalsections(30μm)ofbrainwerecutinacryostatandcollectedinphosphate-bufferedsaline(PBS).1.5.1u3000dex-100/pbs并配使用Sectionswereincubatedin0.1mol/LPBS(pH7.2~7.4)containing0.5%TritonX-100and5%goatserumatroomtemperaturefor2h,andthenthefloatingsectionswereincubatedwithaprimaryanti-bodyforFos(SantaCruz,1:500)in0.5%TritonX-100/PBSat4℃for48h.Afterwashedin0.1mol/LPBS,thesectionswereincubatedwithbiotinylatedsecondaryantibodysolution(1:200)overnightat4℃andthenputintoanavidin-biotin-peroxidasesystem(1:200)for4hatroomtemperature.AfterarinseinPBS,thesectionswereexposedtohydrogenperoxidasetetrahydrochloride(DAB)with0.01%NiCl2·H2Ofor5~10min.AfterarinseinPBS,thesectionswereusedforImmunohistochemistryfornNOS.1.5.2rachindthraceereinvi生物—ImmunohistochemistryfornNOS.Sectionswerethenincubatedin0.1mol/LPBS(pH7.2~7.4)containing0.5%TritonX-100and5%goatserumatroomtemperaturefor2h,andthenthefloatingsectionswereincubatedwithaprimaryanti-bodyfornNOS(SantaCruz,1:500)in0.5%TritonX-100/PBSat4℃for48h.Afterwashedin0.1mol/LPBS,thesectionswereincubatedwithbiotinylatedsecondaryantibodysolution(1:200)overnightat4℃andthenputintoanavidin-biotin-peroxidasesystem(1:200)for4hatroomtemperature.AfterarinseinPBS,thesectionswereexposedtohydrogenperoxidasetetrahydrochloride(DAB)for5~10min.Thesectionswerethenmountedontochromeslidescoatedwithgelatin,dehydratedinalcoholandxylene,coverslippedandviewedunderalightmicroscopy.1.6perterficiensperpetratreprced-非織造s后,kes-stins國(guó)際專(zhuān)家計(jì)劃和stating...........................................................ThenumbersofneuronslabeledforFos,nNOSordouble-labeledforFosandnNOSwerecounted.Foreachbrainarea,3~5sectionswereanalyzedperratandthefinalvaluespresentedintheresultsrepresentthemeanspersectionforoneside.Alldatawereexpressedasmean±standarderror(SE).Comparisonamonggroupswasperformedwithaone-wayANNOVAfollowedbyStudent-Neuman-Keulstest.StatisticalsignificancewasacceptedwhenP<0.05.2miph、nlusing、perikarace,nlusingbros,dendge現(xiàn)實(shí),dend-la標(biāo)準(zhǔn),ve.dendrain-roin-ro.u2004,明顯,u2004TheFos-likeimmunoreative(FLI)neuronsshowedblacknuclei,whereasnNOSimmunohistochemistrywasvisualizedasbrowncolorinperikarya,dendritesandaxons.Double-labeledneuronswerevisualizedasbrown-stainedperikaryacontainingaclearlyblacknucleus.DoublelabelingneuronsforFosandnNOSwereusedtoidentifyactivatedNOproducingneurons.2.1非織造布相對(duì)人pb和非主義的para-短流程I.c.v.administrationofADM(1nmol/kg,3nmol/kg)causedamarkedinductionofFLIinvariousregionsofthebrain.Inthebrainstem,therearemanyFLIcellsinthenucleusofthesolitarytract(NTS),theareapostrema(AP),thelocuscoeruleus(LC)andtheparabrachialnucleus(PB).IncreasedFLIcellswerealsoobservedinthenucleusparagigantocelluarislaterialis(PGL)ofrostralventrolateralmedulla(RVLM).Inthehypothalamus,manyFLIcellswereobservedintheparaventricularnucleus(PVN),thesupraopticnucleus(SON)andtheventromedialhypothalamicnucleus(VMH).Intheforebrain,manyFLIcellswerelocalizedinthecentralamygdaloidnucleus(Ce)andthelateralhabenularnucleus(LHb).AlthoughthepatternofdistributionoftheFLIinthebrainafteri.c.v.administrationof1nmol/kgADMwasnotdifferentfromthatafteradministrationof3nmol/kg,thenumberofFLIcellsafteradministrationof1nmol/kgADMwerefewerthanthatafter3nmol/kg(Table1).2.2采取行動(dòng)。c.v.管理人2.2.1reaseindexofnasin-laeling,又作c.s.i.coInthepresentexperiment,nNOS-labeledneuronsweremainlyfoundinthePVN,SON,VMH,NTS,PGLandPB.I.c.v.injectionofADM(1nmol/kg)ledtoasignificantincreaseinthenumberofnNOS-labeledneuronsinthePVNandSON,andafurthersignificantincreasewasfoundfollowingi.c.v.injectionofADM(3nmol/kg).IncreasednNOS-labeledneuronswerealsoobservedintheNTSandPGLfollowingi.c.v.injectionofADM(3nmol/kg),whilei.c.v.injectionofADM(1nmol/kg)didnotchangethenumberofnNOS-labeledneuronsintheNTSandPGL.ThenumberofnNOS-labeledneuronsinotherbrainareaswasnotaffected(Table2,Fig.1andFig.2).2.2.2保證治療d.c.nmol/admlants/斷裂二通道型分布,即保證二、三nmol/pgl兩個(gè)0.Fewdouble-labeledneuronswerefoundinthePVNandSONofcontrolrats.Followingi.c.v.injectionofADM(1nmol/kg,3nmol/kg),thenumberofdouble-labeledneuronswasincreasedinthePVNandSON.SmallnumbersofdoublelabeledneuronswerealsofoundintheNTSandPGLfollowingi.c.v.injectionofADM(3nmol/kg),whilei.c.v.injectionofADM(1nmol/kg)didnotchangethenumberofdouble-labeledneuronsintheNTSandPGL(Table2,Fig.landFig.2).2.3idren8-33sigmificanting/adm/agfos-liing3g/aggregregf.3g.5.3.3CGRPreceptorantagonistCGRP8-37(30nmol/kg)itselfdidnotinfluencetheinductionofFos-LIandNO-producingneurons.However,PretreatmentwithCGRP8-37significantlyreducedtheeffectsofADM(3nmol/kg)(Fig.3).3子階段3.1程序救濟(jì)相關(guān)程序Inthepresentstudy,wehavedemonstratedthati.c.v.administrationofADMresultedinamarkedinductionofFos-LIinvariousbrainareasoftherat,includingtheforebrain,thehypothalamusandthebrainstem.I.c.v.administrationofADMcauseshypertensionandincreasessympatheticoutflowinanesthetizedandconsciousrats.AlthoughthesiteofactionofADMintheregulationofcardiovascularfunctionintheCNSisunclear,ourexperimentalresultssuggestthattheautonomicneuronsinvariousbrainareasincludingNTS,AP,LC,PGLandPBinthebrainstem,PVN,SONandVMHinthehypothalamus,aswellasCeandLHbintheforebrainareactivatedbyi.c.v.administrationofADM,andmaybeinvolvedinthecentralregulationofthecardiovascularsystem.3.2規(guī)訓(xùn)adm—EffectsonNO-producingneuronsIntheperiphery,ADM-inducedvasodilationisbelievedtobemediatedthroughthereleaseofNO.However,theeffectsofADMonNOproductioninthebrainarenotclear.Ourresultsshowedthati.c.v.administeredADMcanactivateNO-producingneuronsinthePVNandSONofhypothalamus,NTSandPGLofbrainstem.NO-producingneuronsarefoundinautonomiccentersincludingthePVN,SON,NTS,ventrolateralmedulla(VLM)andspinalintermediolateralcellcolumn.IncreasingevidencedemonstratedthatNOsysteminthebrainappearstobeactivatedduringstatesofhomeostaticimbalanceincludingdehydration,hypertensionandstress.OneoftheprimaryrolesofthecentralautonomicNOsystemistore-establishhomeostasisthroughinhibitingsympatheticactivityoutputtoperipheralorgans.I.c.v.administrationofADMstimulatedsympatheticoutput,inducinghypertensionandtachycardia.Thestimulationofsympatheticoutputbyi.c.v.ADMtogetherwiththeinhibitionofsympatheticoutputbyNOinbrainsuggestthattheADM-inducedstimulationoftheNOsysteminbrainmaybepartofafeedforwardloop,whichactstorestorethehomeostaticequilibriumwhichisdisruptedbycentralADM.Ontheotherhand,itisalsopossiblethatcentralNOmediatessomeoftheeffectsofADM.3.3國(guó)際習(xí)慣法—EffectsofCGRP8-37ontheactionsofADMADMisstructurallyhomologoustoCGRPandinteractswithspecificADMreceptorsandCGRP1receptors,andsomeoftheactionsofADMhavebeenshowedtobeblockedbytheCGRPantagonistCGRP8-37,whiletheblockingeffectsofCGRP8-37onthecentralactionsofADMwerecontroversial.Takahashietal.andSaitaetal.reportedthatpretreatmentwithCGRP8-37suppressedthecentraleffectofADM;conversely,Samonetal.didnothavethesameresult.Ourpreviousstudiesshowedthatmicroinjectionofadrenomedullinintorostralventrolateralmedullaincreasesbloodpressure,heartrateandrenals
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年全球及中國(guó)成人電動(dòng)踏板車(chē)行業(yè)頭部企業(yè)市場(chǎng)占有率及排名調(diào)研報(bào)告
- 2025-2030全球聚酯樹(shù)脂行業(yè)調(diào)研及趨勢(shì)分析報(bào)告
- 2025年全球及中國(guó)中心供氧站行業(yè)頭部企業(yè)市場(chǎng)占有率及排名調(diào)研報(bào)告
- 大數(shù)據(jù)分析服務(wù)項(xiàng)目合同
- 2025合同模板股權(quán)合作協(xié)議范本
- 2025企業(yè)管理資料勞務(wù)合同樣本頁(yè)文檔范本
- 鋼質(zhì)防火門(mén)制作安裝合同
- 中介公司房產(chǎn)交易合同范本
- 奶牛場(chǎng)承包經(jīng)營(yíng)合同
- 銷(xiāo)售回購(gòu)合同
- 高考英語(yǔ)單詞3500(亂序版)
- 《社區(qū)康復(fù)》課件-第五章 脊髓損傷患者的社區(qū)康復(fù)實(shí)踐
- 北方、南方戲劇圈的雜劇文檔
- 燈謎大全及答案1000個(gè)
- 白酒銷(xiāo)售經(jīng)理述職報(bào)告
- 部編小學(xué)語(yǔ)文(6年級(jí)下冊(cè)第6單元)作業(yè)設(shè)計(jì)
- 洗衣機(jī)事業(yè)部精益降本總結(jié)及規(guī)劃 -美的集團(tuán)制造年會(huì)
- 2015-2022年湖南高速鐵路職業(yè)技術(shù)學(xué)院高職單招語(yǔ)文/數(shù)學(xué)/英語(yǔ)筆試參考題庫(kù)含答案解析
- 2023年菏澤醫(yī)學(xué)專(zhuān)科學(xué)校單招綜合素質(zhì)模擬試題及答案解析
- 鋁合金門(mén)窗設(shè)計(jì)說(shuō)明
- 小學(xué)數(shù)學(xué)-三角形面積計(jì)算公式的推導(dǎo)教學(xué)設(shè)計(jì)學(xué)情分析教材分析課后反思
評(píng)論
0/150
提交評(píng)論